Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile
- 1 October 2018
- journal article
- research article
- Published by Elsevier BV in Microbial Pathogenesis
- Vol. 123, 42-46
- https://doi.org/10.1016/j.micpath.2018.06.039
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (JP25860327, JP16K19132)
This publication has 30 references indexed in Scilit:
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficileMicrobiology, 2013
- Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?Journal of Hospital Infection, 2012
- Role of fibronectin-binding protein A in Clostridium difficile intestinal colonizationJournal of Medical Microbiology, 2011
- PrsW Is Required for Colonization, Resistance to Antimicrobial Peptides, and Expression of Extracytoplasmic Function σ Factors in Clostridium difficileInfection and Immunity, 2011
- Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community HospitalsInfection Control & Hospital Epidemiology, 2011
- The role of toxin A and toxin B in Clostridium difficile infectionNature, 2010
- Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1Journal of Clinical Microbiology, 2008
- Active immunization of hamsters againstClostridium difficileinfection using surface-layer proteinFEMS Immunology & Medical Microbiology, 2008
- Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficileVaccine, 2007
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970